Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.

The latest figures from the DWP show there are now nearly 1.2 million adults across the UK receiving support through PIP for ...

The Department for Work and Pensions (DWP) has unveiled new stats, showing that nearly 1.2 million adults across Great ...

If your ability to work is limited due to your symptoms, you could qualify for 'new style' Employment and Support Allowance ...

Novartis' Cosentyx Phase 3 REPLENISH trial for polymyalgia rheumatica met primary and secondary endpoints, showing ...

Novartis said that its immunology drug Cosentyx met the primary target and all secondary ones in a late-stage trial for the treatment of patients with inflammatory disease polymyalgia rheumatica.

A logical approach to investigating a case of muscle ‘aches and pains’ to rule out serious pathology and reach a diagnosis ...

Globally, nearly 51% of patients with fibromyalgia had depression, and 47% experienced anxiety in a new meta-analysis. Additionally, there were trends for anxiety prevalence decreasing with age and ...